Filippo Pelizzaro

1.2k total citations
39 papers, 413 citations indexed

About

Filippo Pelizzaro is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Filippo Pelizzaro has authored 39 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 15 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Filippo Pelizzaro's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (9 papers). Filippo Pelizzaro is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (9 papers). Filippo Pelizzaro collaborates with scholars based in Italy, Austria and Germany. Filippo Pelizzaro's co-authors include Fabio Farinati, Francesco Paolo Russo, Patrizia Burra, Marco Senzolo, Alessandro Vitale, Umberto Cillo, Alberto Zanetto, Paolo Simioni, Romilda Cardin and Matteo Fassan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Filippo Pelizzaro

35 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filippo Pelizzaro Italy 13 212 182 93 75 75 39 413
Jong Ryul Eun South Korea 15 304 1.4× 269 1.5× 89 1.0× 84 1.1× 60 0.8× 41 528
Marc Puigvehí Spain 11 358 1.7× 266 1.5× 94 1.0× 35 0.5× 49 0.7× 24 515
Ayşegül Özakyol Türkiye 9 121 0.6× 114 0.6× 75 0.8× 82 1.1× 54 0.7× 25 327
Lucia Cerrito Italy 12 260 1.2× 175 1.0× 106 1.1× 143 1.9× 42 0.6× 40 491
Shingo Usui∥ Japan 14 143 0.7× 208 1.1× 153 1.6× 95 1.3× 60 0.8× 30 599
Alvaro Koch United States 9 288 1.4× 196 1.1× 117 1.3× 109 1.5× 59 0.8× 15 505
M. Guidi Italy 10 310 1.5× 298 1.6× 96 1.0× 74 1.0× 31 0.4× 16 524
Nancy E. Aguilar-Olivos Mexico 14 232 1.1× 301 1.7× 202 2.2× 41 0.5× 29 0.4× 24 523
Keisuke Ojiro Japan 14 293 1.4× 373 2.0× 145 1.6× 70 0.9× 16 0.2× 30 653
Shusuke Kitabatake Japan 12 366 1.7× 351 1.9× 122 1.3× 43 0.6× 33 0.4× 18 549

Countries citing papers authored by Filippo Pelizzaro

Since Specialization
Citations

This map shows the geographic impact of Filippo Pelizzaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Pelizzaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Pelizzaro more than expected).

Fields of papers citing papers by Filippo Pelizzaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Pelizzaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Pelizzaro. The network helps show where Filippo Pelizzaro may publish in the future.

Co-authorship network of co-authors of Filippo Pelizzaro

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Pelizzaro. A scholar is included among the top collaborators of Filippo Pelizzaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Pelizzaro. Filippo Pelizzaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazzarini, Elisabetta, Filippo Pelizzaro, Martina Gambato, et al.. (2025). Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study. Cancers. 17(7). 1115–1115. 1 indexed citations
2.
Zanetto, Alberto, Alessandro Vitale, Filippo Pelizzaro, et al.. (2025). CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma. United European Gastroenterology Journal. 13(5). 728–737. 1 indexed citations
3.
Ferrarese, Alberto, Marco Senzolo, Anna Maria Cattelan, et al.. (2024). Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation. SHILAP Revista de lepidopterología. 5(3). 129–139. 1 indexed citations
4.
Patron, Elisabetta, Simone Messerotti Benvenuti, Filippo Pelizzaro, et al.. (2024). Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates. Journal of Clinical Medicine. 13(13). 3807–3807.
5.
Cardin, Romilda, Debora Bizzaro, Francesco Paolo Russo, et al.. (2024). Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18. Gastroenterology Insights. 15(4). 1093–1105.
6.
Farinati, Fabio, et al.. (2023). Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role?. Digestive and Liver Disease. 56(4). 579–588. 12 indexed citations
7.
Zanetto, Alberto, Filippo Pelizzaro, Monica Mion, et al.. (2023). Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0. United European Gastroenterology Journal. 11(9). 815–824. 12 indexed citations
8.
Pelizzaro, Filippo, Romilda Cardin, Michele Battistel, et al.. (2023). HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization. Digestive and Liver Disease. 56(5). 872–879. 15 indexed citations
9.
Pelizzaro, Filippo, Fabio Farinati, & Franco Trevisani. (2023). Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance. Biomedicines. 11(4). 1020–1020. 12 indexed citations
10.
Scarmozzino, Federico, Marco Pizzi, Filippo Pelizzaro, et al.. (2023). Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges. Frontiers in Oncology. 13. 1273305–1273305. 6 indexed citations
11.
Marzi, Luca, Andrea Mega, Stefano Gitto, et al.. (2022). Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC. Cancers. 14(14). 3332–3332. 13 indexed citations
12.
Zanetto, Alberto, Filippo Pelizzaro, Elena Campello, et al.. (2022). Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. Journal of Hepatology. 78(2). 301–311. 59 indexed citations
13.
Zanetto, Alberto, Elena Campello, Filippo Pelizzaro, et al.. (2022). Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications. Liver International. 42(6). 1229–1240. 25 indexed citations
14.
Ferrarese, Alberto, Giuseppe Sartori, Graziella Orrù, et al.. (2021). Machine learning in liver transplantation: a tool for some unsolved questions?. Transplant International. 34(3). 398–411. 20 indexed citations
15.
Pelizzaro, Filippo, Martina Gambato, Enrico Gringeri, et al.. (2021). Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers. 13(19). 4882–4882. 26 indexed citations
16.
Torres, Maria Corina Plaz, Quirino Lai, Fabio Piscaglia, et al.. (2021). Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of Clinical Medicine. 10(15). 3201–3201. 15 indexed citations
17.
Pelizzaro, Filippo, Ilaria Marsilio, Matteo Fassan, et al.. (2021). The Risk of Malignancies in Celiac Disease—A Literature Review. Cancers. 13(21). 5288–5288. 20 indexed citations
18.
Pelizzaro, Filippo, Romilda Cardin, Camillo Aliberti, et al.. (2021). Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines. 9(8). 890–890. 18 indexed citations
19.
Pelizzaro, Filippo, Romilda Cardin, Camillo Aliberti, et al.. (2020). Scca-Igm in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization: Gender-Related Differences. Biomarkers in Medicine. 14(10). 855–867. 4 indexed citations
20.
Pelizzaro, Filippo, Vincenzo Dadduzio, Davide Pastorelli, et al.. (2019). Capecitabine in advanced hepatocellular carcinoma: A multicenter experience. Digestive and Liver Disease. 51(12). 1713–1719. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Ryul Eun Breakdown of academic impact, for papers by Marc Puigvehí Breakdown of academic impact, for papers by Ayşegül Özakyol Breakdown of academic impact, for papers by Lucia Cerrito Breakdown of academic impact, for papers by Shingo Usui∥ Breakdown of academic impact, for papers by Alvaro Koch Breakdown of academic impact, for papers by M. Guidi Breakdown of academic impact, for papers by Nancy E. Aguilar-Olivos Breakdown of academic impact, for papers by Keisuke Ojiro Breakdown of academic impact, for papers by Shusuke Kitabatake
Rankless by CCL
2026